Saeed Z A, Winchester C B, Ferro P S, Michaletz P A, Schwartz J T, Graham D Y
Department of Medicine, Veterans Affairs Medical Center, Houston, Texas, USA.
Gastrointest Endosc. 1995 Mar;41(3):189-95. doi: 10.1016/s0016-5107(95)70336-5.
We prospectively compared the efficacy of polyvinyl bougies (Savary type) passed over a guide wire and through-the-scope balloons for the dilation of peptic esophageal strictures in a randomized study. Thirty-four patients, 17 in each treatment arm, were studied. At entry, dysphagia was assessed according to a six-point scale (0, unable to swallow; 5, normal). The end-point for dilation was to size 45F or 15 mm. Discomfort during the procedure was graded on a four-point scale (0, no discomfort; 1, mild; 2, moderate; 3, severe discomfort). Follow-up visits were at 1 week, 1 month, 3 months, and every 3 months thereafter for 2 years. At the 1-week visit, the size of esophageal lumen was measured by 8-, 10-, and 12-mm pills. Both devices effectively relieved dysphagia. By life-table analysis, stricture recurrence during the first year of follow-up was similar in both groups, but during the second year, the risk of recurrence was significantly lower in patients whose strictures were dilated with balloons. Other advantages of balloons included the need for fewer treatment sessions to achieve the defined end-diameter for dilation (1.1 + 0.1 versus 1.7 + 0.2, p < .05), and less procedural discomfort (p < .05). The differences in luminal size after dilation, measured by the barium pill test, were not significant. Ability to pass the 12-mm pill and absence of dysphagia were correlated. Our results indicate that both devices are effective in relieving dysphagia, but balloons may have a long-term advantage.
在一项随机研究中,我们前瞻性地比较了经导丝置入的聚乙烯探条(萨瓦里型)和经内镜球囊用于扩张消化性食管狭窄的疗效。研究了34例患者,每个治疗组17例。入组时,根据六点量表(0,无法吞咽;5,正常)评估吞咽困难情况。扩张的终点是达到45F或15mm的尺寸。操作过程中的不适程度按四点量表分级(0,无不适;1,轻度;2,中度;3,重度不适)。随访时间为1周、1个月、3个月,此后每3个月随访一次,共2年。在1周随访时,通过8mm、10mm和12mm的药丸测量食管腔大小。两种器械均能有效缓解吞咽困难。通过寿命表分析,两组在随访第一年的狭窄复发情况相似,但在第二年,球囊扩张狭窄患者的复发风险显著降低。球囊的其他优点包括达到规定扩张终径所需的治疗次数较少(1.1±0.1对1.7±0.2,p<0.05),以及操作不适较少(p<0.05)。通过钡剂药丸试验测量的扩张后腔径大小差异不显著。能通过12mm药丸与无吞咽困难相关。我们的结果表明,两种器械在缓解吞咽困难方面均有效,但球囊可能具有长期优势。